Skip to content

Bradford Hypertension and Alcohol Intervention Trial

Bradford Hypertension and Alcohol Intervention Trial: a randomised cluster trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN85355606
Enrollment
4000
Registered
2015-07-01
Start date
2015-08-01
Completion date
Unknown
Last updated
2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol use disorder in patients with newly diagnosed hypertension Mental and Behavioural Disorders

Interventions

3 arms: use of screening tool AUDIT-C with brief intervention without further referral versus further referral for a full alcohol use disorder assessment via the primary care alcohol liaison team vs

Sponsors

Bradford Districts Clinical Commissioning Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Any patients registered with a GP surgery that forms Bradford Districts Clinical Commissioning Group who is newly diagnosed with hypertension.

Exclusion criteria

Exclusion criteria: Malignant hypertension which requires immediate treatment or hospital admission.

Design outcomes

Primary

MeasureTime frame
Blood pressure reduction (clinic readings) after 12 weeks

Secondary

MeasureTime frame
Reduction in alcohol consumed (AUDIT-C) at 3 months. We are planning to follow up all patients medium to long term in a separately funded study and want to look at annual changes in biometrics (blood pressure, weight), smoking status, updated AUDIT-C as well as healthcare utilisation. There are at present no further concrete plans.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026